Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2009 Mar 15;115(6):1174-84.
doi: 10.1002/cncr.24165.

The impact of pregnancy on breast cancer outcomes in women<or=35 years

Beth M Beadle  1 , Wendy A Woodward, Lavinia P Middleton, Welela Tereffe, Eric A Strom, Jennifer K Litton, Funda Meric-Bernstam, Richard L Theriault, Thomas A Buchholz, George H Perkins
Affiliations
Comparative Study

The impact of pregnancy on breast cancer outcomes in women<or=35 years

Beth M Beadle et al. Cancer. .

Abstract

Background: Some evidence suggests that women with pregnancy-associated breast cancers (PABC) have a worse outcome compared with historical controls. However, young age is a worse prognostic factor independently, and women with PABC tend to be young. The purpose of the current study was to compare locoregional recurrence (LRR), distant metastases (DM), and overall survival (OS) in young patients with PABC and non-PABC.

Methods: Data for 668 breast cancers in 652 patients aged<or=35 years were retrospectively reviewed. One hundred four breast cancers (15.6%) were pregnancy-associated; 51 cancers developed during pregnancy and 53 within 1 year after pregnancy.

Results: The median follow-up for all living patients was 114 months. Patients who developed PABC had more advanced T classification, N classification, and stage group (all P<.04) compared with patients with non-PABC. Patients with PABC had no statistically significant differences in 10-year rates of LRR (23.4% vs 19.2%; P=.47), DM (45.1% vs 38.9%; P=.40), or OS (64.6% vs 64.8%; P=.60) compared with patients with non-PABC. For those patients who developed breast cancer during pregnancy, any treatment intervention during pregnancy provided a trend toward improved OS compared with delaying evaluation and treatment until after delivery (78.7% vs 44.7%; P=.068).

Conclusions: Young patients with PABC had no statistically significant differences in LRR, DM, or OS compared with those with non-PABC; however, pregnancy contributed to a delay in breast cancer diagnosis, evaluation, and treatment. Primary care and reproductive physicians should be aggressive in the workup of breast symptoms in the pregnant population to expedite diagnosis and allow multidisciplinary treatment.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures

The authors made no disclosures.

Figures

FIGURE 1
FIGURE 1
Kaplan-Meier curves for (Left) locoregional recurrence (LRR)-free survival, (Center) distant metastasis (DM)-free survival, and (Right) overall survival for patients aged ≤35 years who were diagnosed with pregnancy-associated breast cancer (PABC) are shown in gray versus the same curves for nonpregnancy-associated breast cancer (non-PABC), as shown in black.
FIGURE 2
FIGURE 2
Kaplan-Meier curves are shown for (Left) locoregional recurrence (LRR)-free survival, (Center) distant metastasis (DM)-free survival, and (Right) overall survival for patients aged ≤35 years who were diagnosed with pregnancy-associated breast cancer (PABC) during pregnancy (“During”) (red) and within 1 year of delivery (“After”) (blue), and non-PABC (black). The P values reflect comparisons between the 2 groups of patients with PABC (During vs After).
FIGURE 3
FIGURE 3
Kaplan-Meier curves are shown for (Left) locoregional recurrence (LRR)-free survival, (Center) distant metastasis (DM)-free survival, and (Right) overall survival for patients aged ≤35 years who were diagnosed with breast cancer during pregnancy based on receipt of treatment (“Any tx”) (gray) compared with no treatment (“None”) (black).
See this image and copyright information in PMC

References

    1. Wallack MK, Wolf JA, Jr, Bedwinek J, et al. Gestational carcinoma of the female breast. Curr Probl Cancer. 1983;7:1–58. - PubMed
    1. Nugent P, O’Connell TX. Breast cancer and pregnancy. Arch Surg. 1985;120:1221–1224. - PubMed
    1. Centers for Disease Control. Natality. Hyattsville, MD: National Center for Health Statistics; 2007. Vital Statistics of the United States, 2002. Vol. I.
    1. Bonnier P, Romain S, Dilhuydy JM, et al. Influence of pregnancy on the outcome of breast cancer: a case-control study. Societe Francaise de Senologie et de Pathologie Mammaire Study Group. Int J Cancer. 1997;72:720–727. - PubMed
    1. Zemlickis D, Lishner M, Degendorfer P, et al. Maternal and fetal outcome after breast cancer in pregnancy. Am J Obstet Gynecol. 1992;166:781–787. - PubMed

Publication types